NVO logo

Novo Nordisk A/S (NVO) Revenue

Annual Revenue

$42.13 B
+$8.41 B+24.95%

December 31, 2024

Summary

Performance

1-Year Change

+24.95%

3-Year Change

+88.06%

5-Year Change

+130.29%

15-Year Change

+147.82%

NVO Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.74%
NVO annual revenue is higher than 97.74% of companies in Healthcare sector

Analysts Estimate

$346.97 B
NVO annual revenue is currently -87.86% lower than the consensus analysts' forecast

High & Low

All-time High

$42.13 B
NVO annual revenue is currently at an all-time high

3-Year Low

$22.40 B
NVO annual revenue is currently +88.06% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NVO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
NVO next annual earnings announcement has not yet been scheduled

OtherNVOprofitabilitymetrics:

Annual EPS

$3.28
NVO annual earnings per share is $3.28

Annual Net Income

$14.65 B
NVO annual net profit is $14.65 billion

Annual Operating Profit

$18.62 B
NVO annual operating income is $18.62 billion

Annual Gross Profit

$35.67 B
NVO annual gross profit is $35.67 billion

Quarterly Revenue

$12.24 B
+$1.73 B+16.50%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+24.62%

3-Year Change

+107.65%

5-Year Change

+154.76%

NVO Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.88%
NVO quarterly revenue is higher than 97.88% of companies in Healthcare sector

Analysts Estimate

$79.90 B
NVO quarterly revenue is currently -84.68% lower than the consensus analysts' forecast

High & Low

All-time High

$12.24 B
NVO quarterly revenue is currently at an all-time high

3-Year Low

$5.90 B
NVO quarterly revenue is currently +107.65% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
NVO next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$10.38 B
NVO quarterly gross profit is $10.38 billion

Quarterly Operating Profit

$5.25 B
NVO quarterly operating income is $5.25 billion

Quarterly Net Income

$4.03 B
NVO quarterly net profit is $4.03 billion

Quarterly EPS

$0.91
NVO quarterly earnings per share is $0.91

TTM Revenue

$42.09 B
+$2.74 B+6.96%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+12.48%

3-Year Change

+88.11%

5-Year Change

+130.12%

NVO TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.5%
NVO TTM revenue is higher than 97.5% of companies in Healthcare sector

Analysts Estimate

$112.48 B
NVO TTM revenue is currently -62.58% lower than the consensus analysts' forecast

High & Low

All-time High

$42.09 B
NVO TTM revenue is currently at an all-time high

3-Year Low

$22.38 B
NVO TTM revenue is currently +88.11% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
NVO next earnings announcement has not yet been scheduled

OtherNVOprofitabilitymetrics:

TTM Gross Profit

$35.64 B
NVO TTM gross profit is $35.64 billion

TTM Operating Profit

$18.62 B
NVO TTM operating income is $18.62 billion

TTM Net Income

$14.65 B
NVO TTM net profit is $14.65 billion

TTM EPS

$3.28
NVO TTM earnings per share is $3.28

NVO Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.9%+24.6%+12.5%
3 y3 years+88.1%+107.7%+88.1%
5 y5 years+130.3%+154.8%+130.1%

NVO Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+88.1%at high+107.7%at high+88.1%
5 y5-yearat high+130.3%at high+176.3%at high+130.1%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

Novo Nordisk A/S Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$42.13 B(+24.9%)
$12.24 B(+16.5%)
$42.09 B(+7.0%)
Sep 2024
-
$10.51 B(+7.0%)
$39.36 B(+5.2%)
Jun 2024
-
$9.82 B(+3.2%)
$37.42 B(+5.3%)
Mar 2024
-
$9.52 B(+0.1%)
$35.54 B(+5.4%)
Dec 2023
$33.72 B(+34.4%)
$9.51 B(+10.8%)
$33.71 B(+9.4%)
Sep 2023
-
$8.58 B(+8.1%)
$30.82 B(+8.5%)
Jun 2023
-
$7.94 B(+3.1%)
$28.41 B(+7.7%)
Mar 2023
-
$7.70 B(+16.4%)
$26.38 B(+5.4%)
Dec 2022
$25.09 B(+12.0%)
$6.61 B(+7.2%)
$25.03 B(+2.9%)
Sep 2022
-
$6.17 B(+4.4%)
$24.31 B(+2.2%)
Jun 2022
-
$5.91 B(-6.8%)
$23.79 B(+2.4%)
Mar 2022
-
$6.34 B(+7.5%)
$23.24 B(+3.8%)
Dec 2021
$22.40 B(+15.2%)
$5.90 B(+4.4%)
$22.38 B(+3.5%)
Sep 2021
-
$5.65 B(+5.5%)
$21.63 B(+3.8%)
Jun 2021
-
$5.35 B(-2.3%)
$20.84 B(+4.6%)
Mar 2021
-
$5.48 B(+6.4%)
$19.92 B(+2.5%)
Dec 2020
$19.45 B(+6.3%)
$5.15 B(+6.0%)
$19.44 B(+1.8%)
Sep 2020
-
$4.86 B(+9.6%)
$19.10 B(+1.9%)
Jun 2020
-
$4.43 B(-11.4%)
$18.75 B(-0.5%)
Mar 2020
-
$5.00 B(+4.1%)
$18.84 B(+3.0%)
Dec 2019
$18.30 B(+3.3%)
$4.81 B(+6.5%)
$18.29 B(+1.4%)
Sep 2019
-
$4.51 B(-0.2%)
$18.03 B(+1.0%)
Jun 2019
-
$4.52 B(+1.4%)
$17.85 B(+0.7%)
Mar 2019
-
$4.46 B(-1.9%)
$17.72 B(+0.1%)
Dec 2018
$17.71 B(+4.2%)
$4.55 B(+5.0%)
$17.71 B(+0.7%)
Sep 2018
-
$4.33 B(-1.4%)
$17.59 B(+0.7%)
Jun 2018
-
$4.39 B(-1.2%)
$17.47 B(+0.9%)
Mar 2018
-
$4.44 B(+0.3%)
$17.31 B(+2.2%)
Dec 2017
$17.00 B(+2.3%)
$4.43 B(+5.3%)
$16.95 B(+0.8%)
Sep 2017
-
$4.21 B(-0.7%)
$16.80 B(+0.5%)
Jun 2017
-
$4.23 B(+3.9%)
$16.73 B(+0.4%)
Mar 2017
-
$4.08 B(-4.9%)
$16.66 B(+0.3%)
Dec 2016
$16.61 B(+3.5%)
$4.29 B(+3.8%)
$16.61 B(+0.3%)
Sep 2016
-
$4.13 B(-0.9%)
$16.56 B(+0.8%)
Jun 2016
-
$4.17 B(+3.6%)
$16.42 B(+1.0%)
Mar 2016
-
$4.02 B(-5.0%)
$16.25 B(+1.3%)
Dec 2015
$16.06 B(+1.4%)
$4.23 B(+6.1%)
$16.05 B(+0.7%)
Sep 2015
-
$3.99 B(-0.4%)
$15.94 B(+0.2%)
Jun 2015
-
$4.01 B(+5.0%)
$15.91 B(+0.2%)
Mar 2015
-
$3.82 B(-7.5%)
$15.87 B(+0.5%)
Dec 2014
$15.84 B(+6.4%)
$4.13 B(+4.3%)
$15.79 B(+1.1%)
Sep 2014
-
$3.96 B(-0.5%)
$15.62 B(+2.0%)
Jun 2014
-
$3.97 B(+6.4%)
$15.31 B(+1.5%)
Mar 2014
-
$3.73 B(-5.7%)
$15.08 B(+1.3%)
Dec 2013
$14.88 B(+10.4%)
$3.96 B(+8.6%)
$14.89 B(+2.2%)
Sep 2013
-
$3.65 B(-2.7%)
$14.57 B(+2.2%)
Jun 2013
-
$3.75 B(+5.9%)
$14.26 B(+2.8%)
Mar 2013
-
$3.54 B(-3.0%)
$13.87 B(+3.0%)
Dec 2012
$13.47 B(+8.7%)
$3.64 B(+9.4%)
$13.47 B(+2.8%)
Sep 2012
-
$3.33 B(-0.9%)
$13.10 B(+1.5%)
Jun 2012
-
$3.36 B(+7.4%)
$12.91 B(+2.2%)
Mar 2012
-
$3.13 B(-4.6%)
$12.63 B(+2.0%)
Dec 2011
$12.39 B(+14.5%)
$3.28 B(+4.6%)
$12.38 B(+2.9%)
Sep 2011
-
$3.14 B(+1.5%)
$12.04 B(+3.7%)
Jun 2011
-
$3.09 B(+7.3%)
$11.60 B(+4.1%)
Mar 2011
-
$2.88 B(-1.9%)
$11.15 B(+3.1%)
Dec 2010
$10.82 B(+13.2%)
$2.94 B(+8.7%)
$10.81 B(+3.3%)
Sep 2010
-
$2.70 B(+2.7%)
$10.47 B(+2.9%)
Jun 2010
-
$2.63 B(+3.4%)
$10.17 B(+2.5%)
Mar 2010
-
$2.54 B(-1.9%)
$9.92 B(+3.7%)
Dec 2009
$9.56 B(+6.3%)
$2.59 B(+7.8%)
$9.57 B(+3.8%)
Sep 2009
-
$2.40 B(+1.1%)
$9.22 B(+1.6%)
Jun 2009
-
$2.38 B(+8.6%)
$9.08 B(+0.6%)
Mar 2009
-
$2.19 B(-2.3%)
$9.02 B(+0.6%)
Dec 2008
$9.00 B(+16.8%)
$2.24 B(-0.9%)
$8.97 B(+1.2%)
Sep 2008
-
$2.26 B(-2.8%)
$8.87 B(+3.8%)
Jun 2008
-
$2.33 B(+9.1%)
$8.54 B(+5.1%)
Mar 2008
-
$2.13 B(-0.3%)
$8.12 B(+5.3%)
Dec 2007
$7.70 B(+18.0%)
$2.14 B(+10.4%)
$7.72 B(+4.4%)
Sep 2007
-
$1.94 B(+1.4%)
$7.39 B(+4.3%)
Jun 2007
-
$1.91 B(+10.8%)
$7.09 B(+4.0%)
Mar 2007
-
$1.73 B(-4.9%)
$6.82 B(+4.3%)
Dec 2006
$6.53 B(+15.9%)
$1.81 B(+10.8%)
$6.54 B(+5.1%)
Sep 2006
-
$1.64 B(-0.2%)
$6.22 B(+3.3%)
Jun 2006
-
$1.64 B(+13.7%)
$6.02 B(+4.2%)
Mar 2006
-
$1.44 B(-3.7%)
$5.78 B(+2.9%)
Dec 2005
$5.63 B(+15.2%)
$1.50 B(+4.1%)
$5.61 B(+1.2%)
Sep 2005
-
$1.44 B(+2.8%)
$5.55 B(+4.2%)
Jun 2005
-
$1.40 B(+9.2%)
$5.33 B(+4.7%)
Mar 2005
-
$1.28 B(-10.4%)
$5.09 B(+3.8%)
Dec 2004
$4.89 B
$1.43 B(+17.5%)
$4.90 B(+5.8%)
Sep 2004
-
$1.22 B(+4.8%)
$4.63 B(+4.6%)
DateAnnualQuarterlyTTM
Jun 2004
-
$1.16 B(+6.0%)
$4.43 B(+3.9%)
Mar 2004
-
$1.09 B(-5.8%)
$4.26 B(+5.3%)
Dec 2003
$4.05 B(+26.6%)
$1.16 B(+14.5%)
$4.05 B(+6.9%)
Sep 2003
-
$1.01 B(+2.3%)
$3.79 B(+4.4%)
Jun 2003
-
$992.25 M(+12.8%)
$3.63 B(+10.3%)
Mar 2003
-
$879.28 M(-2.3%)
$3.29 B(+5.4%)
Dec 2002
$3.20 B(+12.3%)
$900.34 M(+5.5%)
$3.12 B(+3.9%)
Sep 2002
-
$853.80 M(+30.8%)
$3.00 B(+1.9%)
Jun 2002
-
$652.97 M(-8.1%)
$2.94 B(-0.7%)
Mar 2002
-
$710.22 M(-9.2%)
$2.96 B(+1.7%)
Dec 2001
$2.85 B(+10.5%)
$781.92 M(-1.9%)
$2.91 B(+22.2%)
Sep 2001
-
$796.80 M(+18.5%)
$2.38 B(-30.9%)
Jun 2001
-
$672.68 M(+1.7%)
$3.45 B(-3.8%)
Mar 2001
-
$661.56 M(+161.4%)
$3.59 B(-2.1%)
Dec 2000
$2.58 B(+9.4%)
$253.11 M(-86.4%)
$3.66 B(+3.0%)
Sep 2000
-
$1.86 B(+129.8%)
$3.56 B(+41.4%)
Jun 2000
-
$810.58 M(+9.9%)
$2.52 B(+4.0%)
Mar 2000
-
$737.25 M(+398.7%)
$2.42 B(+1.6%)
Dec 1999
$2.36 B(+15.6%)
$147.83 M(-82.0%)
$2.38 B(+2.2%)
Sep 1999
-
$821.66 M(+15.0%)
$2.33 B(+3.1%)
Jun 1999
-
$714.35 M(+2.2%)
$2.26 B(+2.1%)
Mar 1999
-
$699.25 M(+619.8%)
$2.22 B(+4.4%)
Dec 1998
$2.04 B(-20.8%)
$97.15 M(-87.1%)
$2.12 B(-22.2%)
Sep 1998
-
$750.72 M(+12.4%)
$2.73 B(+4.7%)
Jun 1998
-
$668.15 M(+10.4%)
$2.60 B(+1.4%)
Mar 1998
-
$605.00 M(-13.7%)
$2.57 B(+1.2%)
Dec 1997
$2.58 B(+0.2%)
$701.25 M(+11.8%)
$2.54 B(-0.6%)
Sep 1997
-
$627.41 M(-0.7%)
$2.55 B(-0.3%)
Jun 1997
-
$631.76 M(+9.9%)
$2.56 B(+1.4%)
Mar 1997
-
$575.07 M(-19.7%)
$2.52 B(-1.2%)
Dec 1996
$2.57 B(+5.0%)
$716.07 M(+12.7%)
$2.55 B(+4.0%)
Sep 1996
-
$635.32 M(+6.3%)
$2.46 B(+2.4%)
Jun 1996
-
$597.46 M(-1.2%)
$2.40 B(-2.2%)
Mar 1996
-
$604.87 M(-2.1%)
$2.45 B(+1.2%)
Dec 1995
$2.45 B(+15.0%)
$617.87 M(+6.7%)
$2.42 B(+1.2%)
Sep 1995
-
$578.90 M(-11.3%)
$2.40 B(+1.3%)
Jun 1995
-
$652.47 M(+13.4%)
$2.36 B(+5.7%)
Mar 1995
-
$575.16 M(-2.3%)
$2.24 B(+5.3%)
Dec 1994
$2.13 B(+4.9%)
$588.55 M(+7.4%)
$2.13 B(-2.0%)
Sep 1994
-
$547.95 M(+4.2%)
$2.17 B(+4.0%)
Jun 1994
-
$525.81 M(+13.5%)
$2.09 B(+2.0%)
Mar 1994
-
$463.15 M(-26.8%)
$2.04 B(+2.3%)
Dec 1993
$2.03 B(+14.6%)
$633.01 M(+36.2%)
$2.00 B(+9.9%)
Sep 1993
-
$464.66 M(-4.0%)
$1.82 B(+0.6%)
Jun 1993
-
$484.02 M(+15.9%)
$1.81 B(+1.9%)
Mar 1993
-
$417.53 M(-7.9%)
$1.78 B(-0.3%)
Dec 1992
$1.77 B(+15.0%)
$453.56 M(-0.2%)
$1.78 B(-0.8%)
Sep 1992
-
$454.35 M(+0.8%)
$1.80 B(+5.8%)
Jun 1992
-
$450.60 M(+6.3%)
$1.70 B(+7.1%)
Mar 1992
-
$423.75 M(-9.3%)
$1.58 B(+2.4%)
Dec 1991
$1.54 B(+14.2%)
$467.25 M(+31.5%)
$1.55 B(+4.3%)
Sep 1991
-
$355.38 M(+5.1%)
$1.48 B(+1.5%)
Jun 1991
-
$338.30 M(-12.5%)
$1.46 B(+1.4%)
Mar 1991
-
$386.54 M(-4.3%)
$1.44 B(+6.6%)
Dec 1990
$1.35 B(+29.3%)
$403.94 M(+20.9%)
$1.35 B(+7.9%)
Sep 1990
-
$334.06 M(+5.1%)
$1.25 B(+8.7%)
Jun 1990
-
$317.76 M(+6.8%)
$1.15 B(+7.8%)
Mar 1990
-
$297.53 M(-2.4%)
$1.07 B(+2.1%)
Dec 1989
$1.04 B(+24.5%)
$304.81 M(+30.4%)
$1.05 B(+6.7%)
Sep 1989
-
$233.75 M(-0.0%)
$981.87 M(+5.2%)
Jun 1989
-
$233.82 M(-15.0%)
$933.24 M(+2.3%)
Mar 1989
-
$275.14 M(+15.0%)
$912.23 M(+10.9%)
Dec 1988
$838.16 M(+13.9%)
$239.16 M(+29.2%)
$822.23 M(+3.5%)
Sep 1988
-
$185.12 M(-13.0%)
$794.23 M(+0.6%)
Jun 1988
-
$212.81 M(+15.0%)
$789.74 M(+5.5%)
Mar 1988
-
$185.13 M(-12.3%)
$748.69 M(+1.2%)
Dec 1987
$735.83 M(+41.8%)
$211.16 M(+16.9%)
$740.04 M(+11.0%)
Sep 1987
-
$180.64 M(+5.2%)
$666.80 M(+8.3%)
Jun 1987
-
$171.75 M(-2.7%)
$615.56 M(+6.6%)
Mar 1987
-
$176.49 M(+28.0%)
$577.58 M(+11.1%)
Dec 1986
$519.04 M(+31.2%)
$137.92 M(+6.6%)
$519.67 M(+5.4%)
Sep 1986
-
$129.40 M(-3.3%)
$493.06 M(+7.3%)
Jun 1986
-
$133.77 M(+12.8%)
$459.60 M(+9.2%)
Mar 1986
-
$118.58 M(+6.5%)
$421.07 M(+6.6%)
Dec 1985
$395.57 M(+8.3%)
$111.30 M(+16.0%)
$394.99 M(+5.4%)
Sep 1985
-
$95.94 M(+0.7%)
$374.78 M(+1.2%)
Jun 1985
-
$95.24 M(+3.0%)
$370.38 M(+1.1%)
Mar 1985
-
$92.51 M(+1.5%)
$366.30 M(+0.1%)
Dec 1984
$365.11 M
$91.09 M(-0.5%)
$365.94 M(+33.1%)
Sep 1984
-
$91.54 M(+0.4%)
$274.84 M(+49.9%)
Jun 1984
-
$91.16 M(-1.1%)
$183.30 M(+98.9%)
Mar 1984
-
$92.14 M
$92.14 M

FAQ

  • What is Novo Nordisk A/S annual revenue?
  • What is the all time high annual revenue for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual revenue year-on-year change?
  • What is Novo Nordisk A/S quarterly revenue?
  • What is the all time high quarterly revenue for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly revenue year-on-year change?
  • What is Novo Nordisk A/S TTM revenue?
  • What is the all time high TTM revenue for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM revenue year-on-year change?

What is Novo Nordisk A/S annual revenue?

The current annual revenue of NVO is $42.13 B

What is the all time high annual revenue for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual revenue is $42.13 B

What is Novo Nordisk A/S annual revenue year-on-year change?

Over the past year, NVO annual revenue has changed by +$8.41 B (+24.95%)

What is Novo Nordisk A/S quarterly revenue?

The current quarterly revenue of NVO is $12.24 B

What is the all time high quarterly revenue for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly revenue is $12.24 B

What is Novo Nordisk A/S quarterly revenue year-on-year change?

Over the past year, NVO quarterly revenue has changed by +$2.42 B (+24.62%)

What is Novo Nordisk A/S TTM revenue?

The current TTM revenue of NVO is $42.09 B

What is the all time high TTM revenue for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM revenue is $42.09 B

What is Novo Nordisk A/S TTM revenue year-on-year change?

Over the past year, NVO TTM revenue has changed by +$4.67 B (+12.48%)